I0021
IHC- Breast panel 2
Number of Tests | 4 |
Test Included | ER, PR, HER-2/neu, Ki67 |
Test Details: Estrogen receptor (ER) and Progesterone receptor (PR) expression is seen in tumours of female sex steroid hormone responsive tissues such as the breast, endometrium, and ovary. It predicts response to hormonal therapy and is a prognostic marker for survival in breast cancer patients.
Over-expression of HER-2/neu is associated with poor prognosis of breast, ovarian, bladder, pancreatic, stomach, and oesophageal malignancies. It predicts a positive response to a monoclonal antibody, Herceptin/Trastuzumab, targeted against the HER-2/neu receptor.
Ki67 is a nuclear protein linked to the cell cycle. It is a marker of cell proliferation.
![](assets/img/diagnleftimg.png)
Category
Advanced Routine Diagnostics
Pre-test Information
Demographic data, site of the specimen, clinical details & relevant investigations including radiology are mandatory.
Report Delivery
4 working days
Gender
Female
Organ
Breast
IHC- Breast panel 2
4000
Most Searched Diagnostic Tests